People with MS have a higher risk of dying by suicide than the general population, according to a meta-analysis of published ...

Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression in ...

A Phase 2 clinical trial testing PIPE-307, an MS experimental therapy designed to promote myelin repair, failed to meet its ...

PIPE-307, an experimental MS therapy aimed at supporting myelin repair, failed to meet its primary or secondary goals in a Phase 2 trial. The therapy showed no signs of improving vision or other ...

A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults ...

Guest writer Shara Sand says that her severe mood changes went unidentified until a psychiatrist diagnosed her with bipolar ...

Vision changes with SPMS can involve slow visual processing and motion sensitivity, but it’s possible to manage them.

Shara Sand is a practicing psychologist and retired associate professor. She specializes in gender, sexuality, and disability issues and works with creative and performing artists. Shara identifies as ...